Pramiracetam is an inhibitor of PREP and anti-migraine agent. It is a more potent nootropic drug derived from piracetam. Pramiracetam reportedly improved cognitive deficits associated with traumatic brain injuries. It was also effective in the treatment of cognitive disorders of cerebrovascular and traumatic origins.
pramiracetam dosage
The recommended dose of Pramira is 600 mg every 12 hours. The total daily dose should not exceed 1200 mg. Clinically significant results can be expected no earlier than 4-8 weeks of therapy.
Elderly patients. No dose adjustment is required.
Pramiracetam benefits
Pramiracetam powder as a pyrrolidones cerebral metabolism improving drug,is a kind of CNS drugs that can help improve memory, anti-forgetful , it is developed by the United States Parke-Davis pharmaceutical companies, with a strong improvement in brain function, enhancing memory, the ability to promote brain alertness, and clinical trials have proved that its activity is 6-13 times of piracetam, 3-4 times of oxiracetam, 1.25 times of aniracetam, and it is toxicity low and well tolerated, it can be used for long-term medication to improve symptoms, and delay Alzheimer-type dementia.
Clinically relevant for elderly people attention and memory disorders, benign forgetfulness of aging, senile dementia (Alzheimer’s disease) prevention, enhancing memory. Pramiracetam also applies to dilate blood vessels bodybuilding health products additives.
Chemical Properties white crystals
Pramiracetam Side effects
When taken by mouth: Piracetam is POSSIBLY SAFE when taken appropriately. Some people who take piracetam have had nausea, vomiting, weight gain, nervousness, and sleep changes.
When given by IV: Piracetam is POSSIBLY SAFE when given by IV by a healthcare professional.
Melting point 47-48°
Boiling point bp0.15 162-164°
density 1.036±0.06 g/cm3(Predicted)
storage temp. Sealed in dry,2-8°C
solubility H2O: soluble10mg/mL, clear
pka 14.76±0.46(Predicted)
form powder
color white to beige
Merck 14,7706
InChI InChI=1S/C14H27N3O2/c1-11(2)17(12(3)4)9-7-15-13(18)10-16-8-5-6-14(16)19/h11-12H,5-10H2,1-4H3,(H,15,18)
InChIKey ZULJGOSFKWFVRX-UHFFFAOYSA-N
SMILES N1(CC(NCCN(C(C)C)C(C)C)=O)CCCC1=O
CAS DataBase Reference 68497-62-1(CAS DataBase Reference)
More Introduction:https://en.wikipedia.org/wiki/Pramiracetam
